Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical Inc (PRVCF)
OTHER OTC:PRVCF
RESEARCH TOOLSreports
Holding PRVCF?
Track your performance easily
PRVCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.02
Previous Close$0.01
Volume1.50K
Average Volume (3M)36.58K
Market Cap
$7.75M
Enterprise Value$10.75M
Total Cash (Recent Filing)C$234.00
Total Debt (Recent Filing)C$4.20M
Price to Earnings (P/E)―
Beta-0.22
Next Earnings
Apr 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding539,903,359
10 Day Avg. Volume34,582
30 Day Avg. Volume36,579
Standard Deviation0.27
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PreveCeutical Medical News
PremiumCompany Announcements
PreveCeutical Welcomes Expert to Boost Health Research
PremiumCompany Announcements
PreveCeutical’s BioGene Announces Key Leadership Appointments
PremiumCompany Announcements
PreveCeutical Finalizes BioGene Asset Deal
PremiumCompany Announcements
PreveCeutical’s BioGene Names New President
PremiumCompany Announcements
PreveCeutical Partners with BioGene for Asset SalePremiumCompany Announcements
PreveCeutical Partners with Phoenix for Strategic Growth
PremiumCompany Announcements
PreveCeutical Boosts Marketing with OTB Partnership
PremiumCompany Announcements
PreveCeutical Medical Overcomes Trade Hurdle, Advances ResearchOptions Prices
Currently, No data available
---
Ownership Overview
PRVCF FAQ
What was PreveCeutical Medical Inc’s price range in the past 12 months?
PreveCeutical Medical Inc lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.
What is PreveCeutical Medical Inc’s market cap?
Currently, no data Available
When is PreveCeutical Medical Inc’s upcoming earnings report date?
PreveCeutical Medical Inc’s upcoming earnings report date is Apr 30, 2025 which is in 155 days.
How were PreveCeutical Medical Inc’s earnings last quarter?
Currently, no data Available
Is PreveCeutical Medical Inc overvalued?
According to Wall Street analysts PreveCeutical Medical Inc’s price is currently Overvalued.
Does PreveCeutical Medical Inc pay dividends?
PreveCeutical Medical Inc does not currently pay dividends.
What is PreveCeutical Medical Inc’s EPS estimate?
PreveCeutical Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PreveCeutical Medical Inc have?
PreveCeutical Medical Inc has 539,903,400 shares outstanding.
What happened to PreveCeutical Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PreveCeutical Medical Inc?
Currently, no hedge funds are holding shares in PRVCF
---
PreveCeutical Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.70%
Trailing 12-Months
Company Description
PreveCeutical Medical Inc
PreveCeutical Medical, Inc. engages in licensing, branding and marketing of nutraceutical and wellness products. Its product include cellb9 immune system booster, which is an oral solution. PreveCeutical Medical was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
---
Technical Analysis
CNBX Pharmaceuticals
―
Charlotte's Web Holdings
―
RELIEF THERAPEUTICS Holding
―
Ardelyx
―
---